PAVmed, a medical technology company focused on devices, diagnostics and digital health, and its subsidiary, cancer care platform Veris Health, completed a $2.37 million private placement financing.Accredited investors acquired PAVmed securities priced at-the-market and…
Continue Reading
What You Should Know:
– Tempus, a provider of AI-driven precision medicine, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group announced a new collaboration to improve the use of ESR1 testing…
Continue Reading
Three new partnerships aim to use artificial intelligence and cloud technologies to enhance precision medicine, put a lasso around AI-driven and other healthcare cyber risks, and improve care delivery workflows. Memorial Sloan Kettering Cancer Center…
Continue Reading
Coreline Soft announces Australia launch, new FDA approvalSouth Korean medical imaging AI company Coreline Soft has made its way to Australia after securing a partnership with a major medical device supplier.
It entered into a…
Korea University Medical Center announces new AI collabKorea University Medical Center has partnered with Royal Philips for joint research and development of AI-driven solutions assisting neurological and cardiovascular disorder diagnosis.
The five-year collaboration involves setting up a…
What You Should Know:
– Ezra, a innovator in AI-driven cancer screening, today announced that its advanced Ezra Flash AI model has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
– The FDA…
Continue Reading
Groundbreaking £11M AI Initiative Launches
The Department for Health and Social Care (DHSC) has unveiled a revolutionary £11m pilot project that harnesses artificial intelligence to accelerate breast cancer detection. This innovative program will enable radiologists…
Engineers from the University of Hong Kong have developed a generative AI-based imaging method that supports cancer diagnosis. HOW IT WORKS
CytoMAD (Cyto-Morphology Adversarial Distillation) combines AI and microfluidic technology to do label-free imaging of tumours…
A regular panel discussion including the brightest minds in the healthcare industry. With a focus on digital health, DHR holds collaborative conversations with physicians, patients, scientists, creatives, technologists, and executives devoting their efforts to…
Continue Reading
Harrison.ai has recently raised a total of $112 million in a Series C funding round led by Aware Super, ECP, and Horizons Ventures. The earlier reported $20 million investment from the Australian government’s National Reconstruction…
Continue Reading
